3650
Generic Prescriptions
Understanding Therapeutic
Substitution
By Claims and Benefits, Inc, A Noridian Company
CBI UpFront Newsletter October 2006
Not every brand-name drug has a generic equivalent, "but that doesn't necessarilymean you are stuck using a pricier brand-name product," says Bethany Pfister, aclinical pharmacist with Prime Therapeutics, a regional pharmacy benefits manager.
You may be a candidate for a generic alternative.
What's the difference?
The terms "generic equivalent" and "generic alternative" are easy to mix up. Ageneric equivalent is a chemical copy of the brand-name medication, which means ithas the same active ingredients. If you were to switch from a brand-name drug to a
generic equivalent, the dosage would stay the same.
Q: Do insurance companies really care
A generic alternative is a copy of a different brand name drug, but it belongs to thesame class of drugs used to treat a particular condition. A generic alternative has
whether I have a safety program for
been shown to be safe and effective to treat that medical condition, but it may con-
our company?
tain different active ingredients.
A. Any reputable insurance carrier would
If you were to switch from a brand-name drug to a generic alternative, the dosage
be extremely interested in not only the
could be different, Pfister says. This practice is known as therapeutic substitution.
type of program but also how it is imple-
How does therapeutic substation work?
mented and who is responsible for
The selective serotonin reuptake inhibitors, or SSRIs, are an example of the class of
administering/valuating the program.
drugs most commonly used to treat depression, she says. Of the five drugs in thatclass, generic equivalents of four of the brand-name products are available. If a
Just having the "required OSHA/safety
patient was taking the only brand-name product in that class, therapeutic substation
manuals and regulations" sitting on a
could be used to switch to a lower-cost generic alternative.
shelf looks nice but does not reflect a
While therapeutic substitution is a way to help patients save on prescription drugs, it
good safety program/culture. Employee
doesn't work for everyone, Pfister notes. "Be aware that your doctor may have a
attitude/training, loss histories, work
valid medical reason for prescribing a specific brand-name drug," she says. Side
area conditions, management, attitude,
effects, for example, vary by individual, and you might tolerate one drug in the classbetter than others.
etc. are the true measurements of a pro-
gram that works.
Another thing to note is that if you are taking a brand-name medication, your phar-macist may fill a prescription with a generic equivalent unless your doctor writes
If your program has been successful
"brand necessary" on the prescription or you specifically say you want the brand-
"rate credits" may be given on certain
name product. The pharmacy, however, needs permission from your doctor to use a
lines of coverage to reflect your efforts in
generic alternative to drugs that do not have generic equivalents.
maintaining a safe environment for your
Looking to save money?
employees and customers.
Using a generic is one way you can cut your drug costs. Over-the-counter medica-
Visits by the loss control representative
tions are another option.
should be viewed as a positive step that
If the patent on a well-known brand-name product is about to expire, the drug com-
your selected carrier is taking to help
pany may apply to the Food and Drug Administration to sell the product over-the-counter, or OTC. "Selling an over-the-counter drug provides a way for the drug com-
you prevent or reduce losses which bene-
pany to keep the profits of its name brand and to compete with other drugs used to
fits both parties.
treat that condition, including the generic version of the drug," Pfister explains.
There are organizations that specialize in
The same dosage of a well-known heartburn medication, for example, is sold as a
providing the books, manuals and even
brand-name prescription called Prilosec, a generic prescription called omeprazole
conduct the necessary employee training
and an over-the-counter medication called Prilosec OTC. Even though the threedrugs have the same active ingredient and dosage and are expected to have the same
that is required by the various regulatory
effect, the prices vary significantly, Pfister notes. Prilosec OTC costs about 85 per-
laws. Utilizing one of these companies
cent less than brand-name Prilosec and about 55 percent less than generic Prilosec.
may be of benefit to you as then you and
Find out more
your employees can concentrate on per-
If you are looking for ways to reduce your prescription drug costs, initiate a conver-
forming the tasks that make your compa-
sation with your doctor. "Unless patients bring up the subject, physicians generally
ny successful. Contact your insurance
do not know the extent of the patient's insurance coverage or the amount of out-of-
agent if you have questions.
pocket costs the patient is able or willing to pay," Pfister says.
East Central Region Expands
By Dale Lieb, Regional Sales Manager
The states of Minnesota, Iowa and the
products and services we have to offer in
southern portion of South Dakota make up
our entire region.
the East Central Region of Ag States. In
Rob Franklin has been hired as the Account
the past couple years, we have expanded
Executive to handle this new expansion
our target markets to include implement
area for Ag States Group. Rob offices in
dealers, rural telcom companies, beverage
Tulsa, Oklahoma and brings 17 years of
distributors, ethanol plants, biodiesel plants,
insurance experience with him. He most
nurseries, and wholesale food and fruit and
recently worked for Nationwide
Agribusiness in the same territory so he is
Recently, we have expanded our region's
well known in the area. Rob can be
geographical footprint into the states of
reached at (918) 749-2435.
Our Promise to our Customers.
Oklahoma and Arkansas. Our current book
We encourage referrals of customers who
At Ag States Group, we provide clarity to
of business in these states is made up of
may need our services throughout the
risk issues so you can focus on business.
agribusiness and petroleum, but a strong
region to any of our Account Executives.
push is underway to write grain elevators,
Thank you for your past referrals which
bringing more insurance alternatives to
C O N T A C T S
have contributed to our growth. Your cus-
these states. We welcome these new cus-
tomer loyalty provides the solid foundation
Corwin Tufte
tomers to Ag States Group, and also wel-
for our continued growth strategies. Thank
President & General Manager
come any new prospects to explore what
you for your business.
Bill Gleason
Director of Sales
Winners of Visa Gift Card
In the months of August, September, and October we ran a weekly drawing to win a $25
Products Manager
Visa Gift Card. In order to be eligible for this drawing our customers had to submit achange request at www.agstatesgroup.com within that week. The following are all the win-
Wendy Byl
ners from that drawing. Congratulations to them and Thank you for using our newly updated
website offering many new online services.
Mike Phelps
Jill – North Star Bean
Sherri – Chamberlin Distributing
Diversified Services Manager
Cindy – Prince Corporation
Dennis – Farmers Union Oil Co
Bill Willard
Robert – Big Horn Cooperative Marketing
Sharon – Global Organics LLC
Daseke Agency Manager
Pete – Ag Valley Coop
Cheryl – Mouws Feed and Grain
Laura – Murakami Farms Inc
Rick – Agri Coop
Michael – Landmark Services Cooperative
Karen – Centrol Inc
Ag States Group
Dianna – Edwall Chemical Corporation
St. Paul, MN 55164
Phone: 800-548-1494
Fax: 651-355-6359
Source: http://www.daseke.net/media.asp?f=newsletter%20winter%2007.pdf
UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY IN RE SCHERING-PLOUGH Civil Action No. 08-397 (DMC) (JAD) CORPORATION / ENHANCE SECURITIES LITIGATION NOTICE OF PENDENCY OF CLASS ACTION All persons and entities that purchased or acquired Schering-Plough Corporation ("Schering") common stock, 6% mandatory convertible preferred stock maturing August 13, 2010 ("Preferred Stock"), or call options, and/or sold
2013 CLINICIAN'S GUIDE TO PREVENTION AND TREATMENT OF OSTEOPOROSIS Attention Clinicians: It is important to note that the recommendations developed in this Guide are intended to serve as a reference point for clinical decision-making with individual patients. They are not intended to be rigid standards, limits or rules. They can be tailored to individual cases to incorporate personal facts that are beyond the scope of this Guide. Because these are recommendations and not rigid standards, they should not be interpreted as quality standards. Nor should they be used to limit coverage for treatments. This Guide was developed by an expert committee of the National Osteoporosis Foundation (NOF) in collaboration with a multi-specialty council of medical experts in the field of bone health convened by NOF. Readers are urged to consult current prescribing information on any drug, device or procedure discussed in this publication. National Osteoporosis Foundation 1150 17th St., NW, Suite 850, Washington, DC 20036 © REVISED 2013. National Osteoporosis Foundation (NOF). All rights reserved. No part of this Guide may be reproduced in any form without advance written permission from the National Osteoporosis Foundation. BoneSource® is a registered trademark of the National Osteoporosis Foundation. Suggested citation: National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2013.